Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. junior Avg
|
New words:
accretion, argued, bone, brain, branch, breast, Carlo, COSO, counsel, count, denied, Dermavant, dismissed, Eczema, escalation, FAS, graph, hearing, ID, inclusion, itch, Joseph, judgement, LLP, Loerop, mEASI, metastatic, military, Monahan, Monte, nodule, nonproprietary, older, pancreatic, payoff, penetrant, percent, pertain, pertaining, plasma, prejudice, psoriatic, ransomware, reinvestment, rescinded, SAD, sequester, simulation, staggered, startup, summary, surgery, toxicology, Ukraine, unallocated, zunsemetinib
Removed:
adjusted, anniversary, assign, attestation, attributable, attribution, British, brochure, classification, clinically, confirm, consecutive, consisting, copay, David, dissolved, dollar, embodied, escrow, expressing, floating, forfeiture, functional, Gordon, hedging, invoicing, journal, Judge, Kamil, lessee, mandated, McKesson, NIH, notified, occurrence, passage, placement, Pound, prepay, prepayment, privately, reaction, reimbursable, retrospective, ruled, selling, suggest, suspected, thereto, translated, translation, uneven, University, vendor, verruca, vested, vitro, Vixen, Wall, wholesaler
Filing tables
Filing exhibits
Related press release
ACRS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-212095 and 333-256337) and Form S-8 (Nos. 333-255922, 333-238079, 333-230614, 333-223922, 333-220149, 333-216703, 333-210379 and 333-207434) of Aclaris Therapeutics, Inc. of our report dated February 24, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 24, 2022